Novartis, Sandoz face new antitrust claims from US states over generic drug prices
MLex Summary: The Connecticut Attorney General announced that 42 states and territories filed a new lawsuit against Novartis and its subsidiaries Sandoz Group AG and Sandoz AG alleging a systemic campaign...To view the full article, register now.
Already a subscriber? Click here to view full article